Bruce Brockstein to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications Bruce Brockstein has written about Vascular Endothelial Growth Factor A.
Connection Strength
0.034
-
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Cancer. 2009 Oct 01; 115(19):4504-13.
Score: 0.019
-
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.
Score: 0.015